Fewer cold cases slow Reckitt sales

Updated
Nurofen Plus
Nurofen Plus

Drugs and hygiene giant Reckitt Benckiser has revealed under-pressure revenues in Europe and North America as fewer cases of the common cold and flu hit sales of its Nurofen pain-relief range.

The company behind Durex condoms and cleaning product Dettol saw revenues in the transatlantic region drop 1% to £2.3 billion in the six months to June 30 as weak consumer sentiment hit performance.

Advertisement